Pathophysiology of the pelvic floor: Basic physiology, effects of ageing, and menopausal changes

Pelvic Floor Disorders: Imaging and Multidisciplinary Approach to Management

Volumn , Issue , 2010, Pages 25-32

  Fenner, Dee E ^a   Hsu, Yvonne ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Ageing; Collagen; Hormones; Pelvic floor muscles; Vaginal parity

Indexed keywords

EID: 84892792790     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-88-470-1542-5_3     Document Type: Chapter

References (54)

1. Goh JT. Biomechanical and biochemical assessments for pelvic organ prolapse. Curr Opin Obstet Gynecol 2003; 15:391-394.
2. Makinen J, Kahari VM, Soderstrom KO et al. Collagen synthesis in the vaginal connective tissue of patients with and without uterine prolapse. Eur J Obstet Gynecol Reprod Biol 1987;24:319-325.
3. Jackson SR, Avery NC, Tarlton JF et al. Changes in metabolism of collagen in genitourinary prolapse. Lancet 1996;347:1658-1661.
4. Liapis A, Bakas P, Pafiti A et al. Changes of collagen type III in female patients with genuine stress incontinence and pelvic floor prolapse. Eur J Obstet Gynecol Reprod Biol 2001;97:76-79.
5. Chen BH, Wen Y, Li H, Polan ML. Collagen metabolism and turnover in women with stress urinary incontinence and pelvic prolapse. Int Urogynecol J Pelvic Floor Dysfunct 2002;13:80-87.
6. Chen B, Wen Y, Polan ML. Elastolytic activity in women with stress urinary incontinence and pelvic organ prolapse. Neurourol Urodyn 2004;23:119-126.
7. Morgan DM, Iyengar J, DeLancey JO. A technique to evaluate the thickness and density of nonvascular smooth muscle in the suburethral fibromuscular layer. Am J Obstet Gynecol 2003;188:1183-1185.
8. Boreham MK, Wai CY, Miller RT et al. Morphometric analysis of smooth muscle in the anterior vaginal wall of women with pelvic organ prolapse. Am J Obstet Gynecol 2002;187:56-63.
9. Boreham MK, Wai CY, Miller RT et al. Morphometric properties of the posterior vaginal wall in women with pelvic organ prolapse. Am J Obstet Gynecol 2002;187:1501-1508; discussion 1508-1509.
10. Boreham MK, Miller RT, Schaffer JI, Word RA. Smooth muscle myosin heavy chain and caldesmon expression in the anterior vaginal wall of women with and without pelvic organ prolapse. Am J Obstet Gynecol 2001; 185:944-952.
11. Tunn R, DeLancey JO, Quint EE. Visibility of pelvic organ support system structures in magnetic resonance images without an endovaginal coil. Am J Obstet Gynecol 2001; 184:1156-1163.
12. Singh K, Reid WM, Berger LA. Magnetic resonance imaging of normal levator ani anatomy and function. Obstet Gynecol 2002;99:433-438.
13. DeLancey JO, Kearney R, Chou Q et al. The appearance of levator ani muscle abnormalities in magnetic resonance images after vaginal delivery. Obstet Gynecol 2003;101:46-53.
14. Lien KC, Mooney B, DeLancey JO, Ashton-Miller JA. Levatorani muscle stretch induced by simulated vaginal birth.Obstet Gynecol 2004;103:31-40.
15. Hoyte L, Schierlitz L, Zou K et al. Two- and 3-dimensional MRI comparison of levator ani structure, volume, and integrity in women with stress incontinence and prolapse. Am J Obstet Gynecol 2001;185:11-19.
16. Hoyte L, Fielding JR, Versi E et al. Variations in levator ani volume and geometry in women: the application of MR based 3D reconstruction in evaluating pelvic floor dysfunction. Arch Esp Urol 2001;54:532-539.
17. Singh K, Jakab M, Reid WM et al. Three-dimensional magnetic resonance imaging assessment of levator ani morphologic features in different grades of prolapse. Am J Obstet Gynecol 2003;188:910-915.
18. Koelbl H, Saz V, Doerfler D et al. Transurethral injection of silicone microimplants for intrinsic urethral sphincter deficiency. Obstet Gynecol 1998;92:332-336.
19. Hanzal E, Berger E,Koelbl H. Levator ani muscle morphology and recurrent genuine stress incontinence. Obstet Gynecol 1993;81:426.
20. Hoyte L, Jakab M, Warfield SK et al. Levator ani thickness variations in symptomatic and asymptomatic women using magnetic resonance-based 3-dimensional color mapping. Am J Obstet Gynecol 2004;191:856-861.
21. Ikai M, Fukunaga T. Calculation of muscle strength per unit cross-sectional area of human muscle by means of ultrasonic measurement. Int Z Angew Physiol 1968;26:26-32.
22. Jorge JM, Wexner SD, Ehrenpreis ED et al. Does perineal descent correlate with pudendal neuropathy? Dis Colon Rectum 1993;36:475-483.
23. Beevors MA, Lubowski DZ, King DW, Carlton MA. Pudendal nerve function in women with symptomatic utero-vaginal prolapse. Int J Colorectal Dis 1991;6:24-28.
24. Bakas P, Liapis A, Karandreas A, Creatsas G. Pudendal nerve terminal motor latency in women with genuine stress incontinence and prolapse. Gynecol Obstet Invest 2001; 51:187-190.
25. Weidner AC, Barber MD, Visco AG et al. Pelvic muscle electromyography of levator ani and external anal sphincter in nulliparous women and women with pelvic floor dysfunction. Am J Obstet Gynecol 2000;183:1390-1399; discussion 1399-1401.
26. Olsen AL, Smith VJ, Bergstrom JO et al. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 1997;89:501-506.
27. Mant J, Painter R, Vessey M. Epidemiology of genital prolapse: observations from the Oxford Family Planning Association Study. Br J Obstet Gynaecol 1997;104:579-585.
28. Dannecker C, Lienemann A, Fischer T, Anthuber C. Influence of spontaneous and instrumental vaginal delivery on objective measures of pelvic organ support: assessment with the pelvic organ prolapse quantification (POPQ) technique and functional cine magnetic resonance imaging. Eur J Obstet Gynecol Reprod Biol 2004;115:32-38.
29. Sze EH, Sherard GB III, Dolezal JM. Pregnancy, labor, delivery, and pelvic organ prolapse. Obstet Gynecol 2002; 100:981-986.
30. ÓBoyle AL, Woodman PJ, ÓBoyle JD et al. Pelvic organ support in nulliparous pregnant and nonpregnant women: a case control study. Am J Obstet Gynecol 2002;187:99-102.
31. Delancey JOL, Morgan DM, Fenner DE et al. Comparison of levator ani muscle defects and function in women with and without prolapse. Obstet Gynecol 2007;109:296-302.
32. Dietz HP, Lanzarone V. Levator trauma after vaginal delivery. Obstet Gynecol 2005;106:707-712.
33. Fu X, Rezapour M, Wu X et al. Expression of estrogen receptor- alpha and -beta in anterior vaginal walls of genuine stress incontinent women. Int Urogynecol J Pelvic Floor Dysfunct 2003;14:276-281.
34. Ewies AA, Thompson J, Al-Azzawi F. Changes in gonadal steroid receptors in the cardinal ligaments of prolapsed uteri: immunohistomorphometric data. Hum Reprod 2004; 19:1622-1628.
35. Jackson S, James M, Abrams P. The effect of oestradiol on vaginalcollagen metabolism in postmenopausal women with genuine stress incontinence. BJOG 2002;109:339-344.
36. Chen B, Wen Y, Wang H, Polan ML. Differences in estrogen modulation of tissue inhibitor of matrix metalloproteinase-1 and matrix metalloproteinase-1 expression in cultured fibroblasts from continent and incontinent women. Am J Obstet Gynecol 2003;189:59-65.
37. Moalli PA, Talarico LC, Sung VW et al. Impact of menopause on collagen subtypes in the arcus tendineous fasciae pelvis. Am J Obstet Gynecol 2004;190:620-627.
38. Jones NHJR, Healy JC, King LJ et al. Pelvic connective tissue resilience decreases with vaginal delivery, menopause and uterine prolapse. Br J Surg 2003;90:466-472.
39. Moalli PA, Ivy SJ, Meyn LA, Zyczynski HM. Risk factors associated with pelvic floor disorders in women undergoing surgical repair. Obstet Gynecol 2003;101:869-874.
40. Hendrix SL, Clark A, Nygaard EI et al. Pelvic organ prolapse in the WHI; gravity and gravidity. Am J Obstet Gynecol 2002;186:1160-1166.
41. Silfen SL, Ciaccia AV, Bryant HU. Selective estrogen receptor modulators: Tissue specificity and differential uterine effects. Climacteric 1999;2:268-283.
42. Fisher B, Costantino JP, Wickerham DL et al. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998;90:1371-1388.
43. Maenpaa JU, Ala-Fossi SL. Toremifene in postmenopausal breast cancer. Efficacy, safety and cost. Drugs Aging 1997;11:261-270.
44. Goldstein SR, Neven P, Zhou L et al. Raloxifene effect on frequency of surgery for pelvic floor relaxation. Obstet Gynecol 2001;98:91-96.
45. Vardy MD, Lindsay R, Scotti RJ et al. Short-term urogenital effects of raloxifene, tamoxifen, and estrogen. Am J Obstet Gynecol 2003;189:81-88.
46. Waetjen LE, Dwyer PL. Estrogen therapy and urinary incontinence: what is evidence and what do we tell our patients? Int Urogynecol J 2006;17:541-545.
47. Jarmy-Di Bella ZI, Girao MJ, Sartori MF et al. Doppler of the urethra in continent and incontinence, pre- and postmenopausal women. Int Urogynecol J 2000;11:148-154.
48. Sacco F, Rigon G, Carbone A, Sacchini D. Transvaginal estrogen therapyin urinary stress incontinence. Merva Ginecol 1990;42:539-544.
49. Elia G, Bergman A.Estrogen effects on the urethra: beneficial effects in women with genuine stress incontinence. Obstet Gynecol Surv 1993;48:509-517.
50. Bergman A, Karram M, Bhatia N. Changes in urethral cytology following estrogen administration. Gynecol Obstet Invest 1990;29:211-213.
51. Bhatia N, Bergman A, Karram M. Effects of estrogen on urethral function in women with urinary incontinence. Am J Obstet Gynecol 1989;160:176-181.
52. Gebhardt J, Richard D, Barrett T. Expression of estrogen receptor isoforms alpha and beta messenger RNA in vaginal tissue of premenopausal and postmenopausal women. Am J Obstet Gynecol 2001;185:1325-1330.
53. Keane DP, Sims TJ, Abrams P, Bailey AJ. Analysis of collagen status in premenopausal nulliparous women with genuine stress incontinence. Br J Obstet Gynecol 1997; 104:994-998.
54. Falconer C, Ekman-Ordeberg G, Blomgren B. Paraurethral connective tissue in stress incontinent women after menopause. Acta Obstet Gynecol Scand 1998;77:95-100.